Azenta’s (AZTA) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Azenta (NASDAQ:AZTA) in a report issued on Monday morning,Benzinga reports. Needham & Company LLC currently has a $37.00 price target on the stock.

Separately, Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 26th. Four research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $41.20.

Azenta Trading Up 0.5%

NASDAQ AZTA opened at $33.21 on Monday. The company has a fifty day simple moving average of $30.68 and a 200 day simple moving average of $25.41. The company has a market cap of $1.45 billion, a P/E ratio of -12.03 and a beta of 1.39. Azenta has a 1 year low of $15.93 and a 1 year high of $41.73.

Azenta (NASDAQ:AZTA) last posted its earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. The business had revenue of $161.18 million for the quarter, compared to analyst estimates of $149.31 million. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%.

Institutional Trading of Azenta

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Rockefeller Capital Management L.P. increased its position in shares of Azenta by 98.0% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,392 shares of the company’s stock valued at $46,000 after acquiring an additional 689 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Azenta by 7.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 9,788 shares of the company’s stock worth $326,000 after purchasing an additional 697 shares during the last quarter. Kera Capital Partners Inc. increased its position in shares of Azenta by 7.7% during the 4th quarter. Kera Capital Partners Inc. now owns 11,034 shares of the company’s stock worth $367,000 after purchasing an additional 787 shares during the last quarter. KBC Group NV raised its stake in shares of Azenta by 102.2% during the 1st quarter. KBC Group NV now owns 2,449 shares of the company’s stock worth $52,000 after purchasing an additional 1,238 shares in the last quarter. Finally, Integrated Wealth Concepts LLC acquired a new stake in shares of Azenta in the 2nd quarter valued at approximately $39,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

About Azenta

Azenta, Inc (NASDAQ: AZTA) is a life sciences company that provides solutions for the management, storage, and analysis of biological samples. Its customers include pharmaceutical and biotechnology companies, academic and government research institutions, clinical research organizations, and other organizations involved in drug discovery, clinical research, and genomic analysis.

The company offers automated sample-management systems, ultra-low-temperature and cryogenic storage equipment, laboratory automation, consumables, and software for tracking and managing biological specimens.